Skip to Main Content

An experimental drug being developed by Acadia Pharmaceuticals improved the symptoms of women and girls with Rett syndrome, a rare genetic disease that robs patients of the ability to interact socially and can cause seizures and other neurological problems, the company said Monday.

The data were made public in a press release and have not yet been peer-reviewed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment